Top news and stories from EWORLDWIRE http://www.eworldwire.com/ http://www.eworldwire.com/logos/logo40x60.gif http://www.eworldwire.com/ 40 60 (C) Copyright 2007 EWORLDWIRE Wed, 05 Sep 2007 16:12:13 -0400 http://www.eworldwire.com/pressreleases/10778 NephroGenex Inc., a new biotechnology company developing treatments for kidney disease utilizing the latest scientific advancements in molecular profiling, completed a seed funding of $500,000. Structured as a promissory note convertible to preferred stock, the financing was led by Discovery Life Sciences Fund, L.P., Vanderbilt University of Nashville, Tenn., and Karolinska Innovations AB of Stockholm, Sweden. [EWORLDWIRE] Mon, 08 Nov 2004 09:04:02 -0500